New Limit(PRIVATE)

An epigenetic reprogramming company co-founded by Brian Armstrong.

2 Insights

Investment Insights

AI-generated insights about New Limit from various financial sources

Wednesday, March 25, 2026

Very Bullish

Uses AI to computationally solve the discovery process for cellular reprogramming; highlighted as a key company in the longevity sector.

Tuesday, February 24, 2026

Very Bullish

Part of a wave of high-profile longevity startups backed by major tech billionaires.